Journals / Klinik Psikiyatri Dergisi / 2010 / Cilt: 13 - Sayı: 2

Sexual dysfunction in schizophrenia: A cross-sectional evaluation

Şizofrenide cinsel işlev bozuklukları: Kesitsel bir değerlendirme

Pages
55–64
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Clinician should talk to their patients on this topic to pinpoint the source of the problem and to minimize them, to enhance the quality of life and treatment compliance.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Aim of this study was to investigate the prevalence of sexual dysfunction and associated clinical and sociodemographic variables and sexual side effects of antipsychotic drugs among patients with schizophrenia who are regularly followed in psychotic disorders outpatient unit.
📊
Key Findings & Data:Mean age was 42.80±9.95 years.
💡
Conclusion & Impact:Clinician should talk to their patients on this topic to pinpoint the source of the problem and to minimize them, to enhance the quality of life and treatment compliance.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Aim of this study was to investigate the prevalence of sexual dysfunction and associated clinical and sociodemographic variables and sexual side effects of antipsychotic drugs among patients with schizophrenia who are regularly followed in psychotic disorders outpatient unit. Method: Forty three patients with schizophrenia were recruited among outpatients of Psychotic Disorders Unit. A patient registry form was used to collect sociodemographic and clinical variables. Sexual dysfunction was evaluated by using Turkish version of Golombok-Rust Sexual Satisfaction Inventory. Results: Seventy-four percent were male. Mean age was 42.80±9.95 years. Problem in sexual intercourse frequency was 77.4%; problem in communication during sex was 48.8%; problem in sexual satisfaction was 27.9 %; problem in sexual aversion was 48.8 % and problem in sexual contact was 4.65 % among patients with schizophrenia. Conclusion: Results of our study is similar to the relevant literature. In addition to a life-long course and impairment of functionality in patients with schizophrenia, there are a variety of serious problems in sexual functionality due to both natural course and applied pharmacotherapy. There are many factors increasing the frequency of sexual dysfunction, and thus decreasing the quality of life and causing incompliance to drug usage. Clinician should talk to their patients on this topic to pinpoint the source of the problem and to minimize them, to enhance the quality of life and treatment compliance.

Özet

Amaç: Bu çalışmanın amacı psikotik bozukluk birimimizde düzenli olarak izlenmekte olan şizofreni hastaları arasında cinsel işlev bozukluğu yaygınlığını ve bunun klinik ve sosyodemografik değişkenler, antipsikotik ilaçların yan etkileri ile ilişkisini araştırmaktır. Yöntem: Şizofreni tanılı kırküç hasta çalışmaya dahil edildi. Hastaların sosyodemografik ve klinik değişkenleri hasta kayıt formu kullanılarak toplandı. Cinsel işlev bozuklukları Golombok-Rust Cinsel doyum ölçeği kullanılarak değerlendirildi. Bulgular: Hastaların %74'ü erkekti. Ortalama yaşları 42.8±9.95 idi. Hastaların %74.4'ünde cinsel ilişki sıklığı; %48.8'inde cinsel iletişim; %27.9'unda cinsel doyum; %48.8'inde kaçınma; %4.65'inde dokunma alanlarında sorun belirlenmiştir. Tartışma: Çalışma bulgularımız bu alanda literatürde yayınlanmış çalışmalarla benzerdir. Şizofreninin yaşa boyu seyri ve işlevsellikte yaptığı bozulmaya ek olarak hastalığın doğal seyrine ve kullanılan ilaçlara bağlı olarak cinsel işlevlerde ciddi problemler vardır. Cinsel işlev bozukluğu yaygınlığını artırıp, dolayısıyla yaşam kalitesini azaltan ve ilaç uyumunu bozan çok sayıda faktör vardır. Klinisyen tarafından bu konunun hastalarla konuşulması, sorun kaynaklarının belirlenerek azaltılması hastaların yaşam kalitesi ve tedaviye uyum açısından yararlı olacaktır.

🔖

Cite This Article

ÇAKMAK, S., KARAKUŞ, G., EVLİCE, Y. E. (2010). Sexual dysfunction in schizophrenia: A cross-sectional evaluation. Klinik Psikiyatri Dergisi, Cilt: 13 - Sayı: 2, 55–64. https://ajindex.com/articles/195936

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Atmaca M, Kuloğlu M, Tezcan E (2005) A new atypical antipsychotic: quetiapine-induced sexual dysfunctions. Int J Impot Res, 17:201-203.
  2. Baggaley M (2008) Sexual dysfunction in schizophrenia: focus on recent evidence. Hum Psychopharmacol Clin Exp, 23:201- 209. Brambilla F (1980) Neuroendocrine function in schizophrenia. Acta Psychiatr Belg, 80:421-435.
  3. Byerly MJ, Nakonezny PA, Fisher R ve ark. (2006) An empirical evaluation of the Aizona Sexual experience scale and a simple one-item screening test for assessing antipsychotic-related sexual dysfunction in outpatients with schizophrenia and schizoaffective disorder. Schizophr Res, 81:311-316.
  4. Deanna LK, Robert RC (2004) Sexuality and schizophrenia: a review. Schizophr Bull, 30:767-779.
  5. Dossenbach M, Erol A, El Mahfoud Kessaci M ve ark. (2004) IC-SOHO Study Group Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational Study (IC-SOHO) comparing olanzapine, quetipapine, risperidone and holoperidol. J Clin Psychiatry, 65:312-321.
  6. Feldman HA, Goldstein I, Hatzichristou DG ve ark. (1994) Impotence and Its Medical and Psychosocial correlates: Results of the Massachusets Male Aging Study. J Urol, 151:54-61.
  7. First MB, Spitzer RL, Gibbon M ve ark. (1997) Structuredclinical interview for DSM-IV clinical version. American Psychiatric press, Washington D.C. Ghadrian AM, Chouinard G, Annable L (1982) Sexual dysfonction and plasma prolactin levels in neuroleptic-treated schizoprenic outpatients. J Nerv Ment Dis, 170:463-467.
  8. Guy W (1976) Clinical Global Impressions. ECDEU Assessment Manual for Psychopharmacology, revised. National Institute of Mental Health, Rockville, MD. Kesebir S, Pırıldar Ş (2003) şizofrenide üreme ve cinsel işlevler: antipsikotik sağaltımın etkisi. Bull Clin Psychopharmacol, 13:88- 93. Knegtering R, Castelein S, Bous H ve ark. (2004) A randomized open-label Study of the impact of quetiapine versus risperidone on sexual functioning. J Clin Psychopharmacol, 24:56-61.
  9. Laumann EO, Paik A, Raymond C ve ark. (1999) Sexual dysfunction in the United States Prevalence and predictors. JAMA, 281:537-544.
  10. Laumann EO, Nicolossi A, Glasser DB ve ark. (2005) Sexual problems among women and men aged 40-80y: Prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res, 17:39-57.
  11. Laumann EO, Nicolossi A, Glasser DB ve ark. (2005) Sexual Problems among women and men aged 40-80y: Prevalence and correlates identifi